Motavizumab
Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research[1].
Product Specifications
CAS Number
[677010-34-3]
Product Name Alternative
MEDI-524
UNSPSC
12352203
Target
RSV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/motavizumab.html
Purity
99.17
Solubility
10 mM in DMSO
Smiles
[Motavizumab]
Molecular Weight
(145.32 kDa)
References & Citations
[1]Mejías A, et al. Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model. Virol J. 2007 Oct 25;4:109.|[2]Huang K, et al. Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion. J Virol. 2010 Aug;84 (16) :8132-40.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal SFMBT2 Antibody (PCRP-SFMBT2-1B7) [Alexa Fluor 532]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP3-24306AF532 0.1 mL
Mouse Monoclonal SFMBT2 Antibody (PCRP-SFMBT2-1B7) [Alexa Fluor 532]
Ask
View Details 
MBS1179702-01 0.02 mg (E-Coli)
Recombinant Mouse EGF-like repeat and discoidin I-like domain-containing protein 3 (Edil3)
Ask
View Details MBS1179702-02 0.02 mg (Yeast)
Recombinant Mouse EGF-like repeat and discoidin I-like domain-containing protein 3 (Edil3)
Ask
View Details